Medical/Pharmaceuticals
Amcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer Packaging
CHICAGO and MELBOURNE, Australia, June 11, 2019 /PRNewswire/ -- Amcor today announces the successful completion of its acquisition of Bemis Company Inc., effective11 June 2019. The combined company will now operate as Amcor plc (Amcor), trading on the New York Stock Exchange under the ticker symb...
2019-06-11 21:46
3176
GT Apeiron Therapeutics launched by GT Healthcare Capital Partners signs with Exscientia
SHANGHAI, June 11, 2019 /PRNewswire/ -- GT Apeiron Therapeutics ("Apeiron"), a novel biotechnology company, was launched with the backing from GT Healthcare and associated investors. The company also entered into a drug discovery collaboration with Exscientia, which utilizes artificial intellige...
2019-06-11 16:00
1962
Collaborative Medicinal Development, LLC Reports that Lead Drug Shows Dose-Dependent Improvement in Parkinson's Disease
MILL VALLEY, California, June 10, 2019 /PRNewswire/ -- Collaborative Medicinal Development LLC ("CMD"), a privately-held biopharmaceutical company developing innovative therapies for neurodegenerative diseases, will report promising results from its phase 1, non-placebo controlled, dose-finding s...
2019-06-10 20:00
1772
Sihuan's Abstracts regarding Clinical Trial Progress of SGLT-2 Inhibitor Selected for Poster Presentation at the American Diabetes Association's Scientific Sessions
HONG KONG, June 10, 2019 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460), the largest cardio-cerebral vascular drug manufacturer in China's prescription drug market, announced that three abstracts regarding the clinical trial of the Group's patented innovative drug Janaglif...
2019-06-10 16:28
6875
CStone and Bayer announce global collaboration to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib
SUZHOU, China, June 9, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) today announced that the company has entered into a global clinical collaboration withChina focus with Bayer HealthCare LLC to evaluate the safety, tolerability, pharmacokinetics (PK) and antitumor activity ...
2019-06-10 09:30
7336
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal l...
2019-06-06 18:00
8464
CStone received approval to initiate clinical development in China of CS1001 and BLU-554 (CS3008) in combination therapy for HCC
SUZHOU, China, June 5, 2019 /PRNewswire/ -- CStone Pharmaceuticals (CStone; HKEX: 2616) announced that it has received approval to initiate clinical development inChina of CS1001 in combination with BLU-554 (CS3008) in patients with locally advanced or metastatic hepatocellular carcinoma (HCC). T...
2019-06-05 19:56
7052
New Instrument for Automated Antimicrobial Susceptibility Testing Provides Gold Standard-Level Minimum Inhibitory Concentration (MIC) Accuracy(1)
Instrument utilizes gold standard broth microdilution method to guide more targeted patient therapy and optimize patient outcomes BASINGSTOKE, England, June 4, 2019 /PRNewswire/ -- A new benchtop automated reading and incubation system is now available inEurope for antimicrobial susceptibility t...
2019-06-04 14:00
3342
Ascentage Pharma presents new clinical data of apoptosis-targeted drug candidates APG-115 and APG-1387 at 2019 ASCO
SUZHOU, China and CHICAGO, June 3, 2019 /PRNewswire/ -- Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases, today announced that the company presented new data of two apoptosis-ta...
2019-06-04 07:00
2414
Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa
Highlights: * 42% investigator-assessed ORR achieved in patients with advanced PEComa – a rare sarcoma with no currently approved therapy * First prospective clinical study in advanced PEComa shows durable responses with nab-sirolimus with a manageable safety profile * 62% of all responding...
2019-06-04 06:39
2489
Saluda Medical Announces Clinical Study Results for Evoke® ECAP-Controlled, Closed-Loop SCS System for the Treatment of Chronic Pain
New Results Highlight the Importance of Objective Neurophysiological Measures and Clinically Meaningful Functional Outcomes ARTARMON, Australia, June 3, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced data from two clinical studies evaluating the performance of...
2019-06-03 16:00
2282
CStone submits new drug application for TIBSOVO(R) in Taiwan for the treatment of relapsed/refractory AML
HONG KONG, June 2, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) announced that a new drug application (NDA) for TIBSOVO® (ivosidenib) has been submitted by a third-party to the Taiwan Food and Drug Administration (TFDA) as the first to-be-approved treatment of adult patients...
2019-06-03 11:45
5725
EmeTerm and HeadaTerm Approved by TGA Australia
VANCOUVER, British Columbia, May 31, 2019 /PRNewswire/ -- WAT Medical, a company that develops safe, effective, and user-friendly wearable medical products, recently announced that HeadaTerm, its migraine treatment product, has received official clearance from TGA Australia. With a team of devote...
2019-05-31 21:00
2887
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
PHILADELPHIA, May 31, 2019 /PRNewswire/ -- Iovance Biotherapeutics, a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, has expanded its relationship with WuXi AppTec's Advanced Therapies Business Unit (WuXi ATU). Wu...
2019-05-31 20:00
2905
111, Inc. to Attend the Credit Suisse 2019 Asia Healthcare Corporate Days in Hong Kong, June 5-6, 2019
SHANGHAI, May 31, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will participate in the Credit Suisse 2019 Asia Healthcare Corporate Days inHong Kong, June 5-6, 2019. Mr. Luke Ch...
2019-05-31 19:15
6778
111, Inc. to Attend the T.H. Capital China TechNet + Investment Conference in Beijing, June 3-4, 2019
SHANGHAI, May 31, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will present at the T.H. Capital China TechNet + Investment Conference inBeijing, June 3-4, 2019. Dr. Gang Yu, Co-...
2019-05-31 17:56
6505
CartiHeal's Agili-C™ Implant Enhances In-vitro Osteogenic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells
KFAR SABA, Israel, May 30, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of osteochondral and chondral defects, announced today the publication of anin-vitro study demonstrating that the Agili-C™ implant enhances osteogenic differentiation of human...
2019-05-30 20:00
1986
Conagen announces formation of Scientific Advisory Board
Board includes five world-leading scientists in the fields of Synthetic Biology and Applied Molecular Biology BEDFORD, Massachusetts, May 30, 2019 /PRNewswire/ -- Conagen Inc., a vertically integrated synthetic biology and fermentation company, announced today the formation of a new scientific ...
2019-05-30 20:00
2149
Singlera Genomics ColonES test selected as finalist for AACC Disruptive Technology Award
SAN DIEGO, May 29, 2019 /PRNewswire/ -- Singlera Genomics, which focuses on non-invasive early cancer detection through circulating tumor DNA methylation haplotyping analysis, was selected as one of three finalists for the second annual AACC Disruptive Technology Award. AACC Disruptive Technolo...
2019-05-29 21:00
1238
CE Certification for AI-based Medical Solutions of JLK Inspection: AI-based Brain Image Analysis (JBS-01K) and AI-based Prostate Image Analysis (JPC-01K) Solutions
SEOUL, South Korea, May 29, 2019 /PRNewswire/ -- JLK Inspection
2019-05-29 20:30
1479
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
5637
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
2024-04-22 16:00
4443
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
2024-04-22 06:00
4038
TCTM Filed 2023 Annual Report on Form 20-F
2024-04-20 05:48
3319
Dingdong Files Its Annual Report on Form 20-F
2024-04-20 05:00
3062